The pharmacological properties of slow Ca 2 ϩ -activated K ϩ current (K slow ) were investigated in mouse pancreatic ␤ -cells and islets to understand how K slow contributes to the control of islet bursting, [Ca 2 ϩ ] i oscillations, and insulin secretion. K slow was insensitive to apamin or the K ATP channel inhibitor tolbutamide, but UCL 1684, a potent and selective nonpeptide SK channel blocker reduced the amplitude of K slow tail current in voltage-clamped mouse ␤ -cells. K slow was also selectively and reversibly inhibited by the class III antiarrythmic agent azimilide (AZ). In isolated ␤ -cells or islets, pharmacologic inhibition of K slow by UCL 1684 or AZ depolarized ␤ -cell silent phase potential, increased action potential firing, raised [Ca 2 ϩ ] i , and enhanced glucose-dependent insulin secretion. AZ inhibition of K slow also supported mediation by SK, rather than cardiac-like slow delayed rectifier channels since bath application of AZ to HEK 293 cells expressing SK3 cDNA reduced SK current. Further, AZ-sensitive K slow current was extant in ␤ -cells from KCNQ1 or KCNE1 null mice lacking cardiac slow delayed rectifier currents. These results strongly support a functional role for SK channel-mediated K slow current in ␤ -cells, and suggest that drugs that target SK channels may represent a new approach for increasing glucose-dependent insulin secretion. The apamin insensitivity of ␤ -cell SK current suggests that ␤ -cells express a unique SK splice variant or a novel heteromultimer consisting of different SK subunits.
I N T R O D U C T I O N
When exposed to glucose concentrations Ն 7 mM, pancreatic islets of Langerhans exhibit electrical oscillations consisting of bursts of fast Ca 2 ϩ -dependent action potentials riding upon slower depolarizing plateaus (Dean and Matthews, 1970a; Ashcroft and Rorsman, 1989; Cook et al., 1991; Satin and Smolen, 1994) . The period of this bursting typically ranges from tens of seconds to minutes in 11.1 mM glucose, and numerous studies have shown that bursting leads to concomitant oscillations in islet [Ca 2 ϩ ] i that drive insulin secretion (Bergsten et al., 1994; Barbosa et al., 1998; Zhang et al., 2003) . However, despite extensive investigation, the ionic basis of islet pacemaking is not fully understood. The cyclic activation of a Ca 2 ϩ -activated K ϩ current (K Ca ) has been a strong candidate pacemaker (Atwater et al., 1979; Satin and Smolen, 1994; Sherman, 1996) , and in support of this, islet bursting is simulated by models incorporating the cyclic activation and deactivation of K Ca channels by bursting-induced elevations in [Ca 2 ϩ ] i (Chay and Keizer, 1983) . Göpel et al. (1999) presented evidence that K slow , a novel slow Ca 2 ϩ -activated K ϩ current, tracks [Ca 2 ϩ ] i as it rises in response to a voltage clamp command designed to mimic an islet burst. Unlike the fast or "BK type" K Ca channels of ␤ -cells (Kukuljan et al., 1991) , K slow was insensitive to charybdotoxin or low concentrations of TEA (Göpel et al., 1999; Hennige et al., 2000) , but was regulated by both store and cytoplasmic Ca 2 ϩ (Goforth et al., 2002) . In contrast to their initial description of the current (Gö-pel et al., 1999) , Kanno et al. (2002) suggested that K slow might be a mosaic of K ATP and Ca 2 ϩ -activated K ϩ current. More recently, Tamarina et al. (2003) confirmed that small-conductance calcium-activated K ϩ channels (SK type) are expressed in pancreatic islets, and suggested these channels regulate glucose-induced [Ca 2 ϩ ] i oscillations in islets by mediating K slow . However, a problem with this hypothesis is that apamin, the canonical SK blocker in other systems, does not affect mouse islet bursting or ␤ -cell K slow current (Lebrun et al., 1983; Ämmälä et al., 1993; Göpel et al., 1999; Goforth et al., 2002) . Thus, it is not yet proven that SK channels mediate K slow current in ␤ -cells. The lack of a selective K slow blocker has further hampered progress in determining Calcium-activated K ϩ Current in Islet ␤ -Cells the function role of K slow current in islet electrophysiology and stimulus-secretion coupling.
We now report that UCL 1684, a highly selective, nonpeptidergic blocker of SK channels (Rosa et al., 1998) , or azimilide (NE-10064, (E)-1- [[[5-(4-chlorophenyl) -2-furanyl]methylene]amino]-3-[4-(4-methyl-1-piperazinyl)butyl]-2,4-imidazolidinedione dihydrochloride, AZ), a novel class III antiarrhythmic agent, inhibit K slow in mouse pancreatic ␤ -cells or islets. In cardiac cells, AZ blocks both the slowly (I Ks ) and rapidly activating (I Kr ) components of delayed rectifier potassium current and as a result prolongs cardiac refractoriness (Busch et al., 1994; Fermini et al., 1995; Salata and Brooks, 1997; Karam et al., 1998) . In islets, however, K slow blockade by AZ was due to block of Ca 2 ϩ -activated SK channels because we found that, on the one hand, AZ was effective in blocking K slow even in ␤ -cells from mice in which I Ks was eliminated by two different global knockouts, and on the other hand, AZ blocked SK3 channels expressed in transfected HEK 293 cells. In terms of function, suppression of K slow by UCL 1684 or AZ resulted in membrane depolarization, increased action potential firing, and a concomitant increase in islet ␤ -cell [Ca 2 ϩ ] i . In islets exhibiting regular [Ca 2 ϩ ] i oscillations in 11.1 mM glucose (Zhang et al., 2003) , UCL or AZ increased [Ca 2 ϩ ] i as well as oscillation frequency. Furthermore, both K slow blockers significantly enhanced glucose-dependent insulin release, while not affecting basal secretion.
M A T E R I A L S A N D M E T H O D S
Culture of Islets and Islet ␤ -Cells Mouse islets were isolated from the pancreases of Swiss-Webster mice by collagenase digestion (Zhang et al., 2003) . Islets were dispersed into single cells by gently shaking the islets in a low-calcium solution. Islets or ␤ -cells were seeded on glass coverslips in 35-mm Petri plates and cultured in RPMI-1640 medium with 11.1 mM glucose, FBS, l -glutamine, and penicillin/streptomycin (Invitrogen) . All cultures were kept at 37 Њ C in an air/CO 2 incubator. Cells were fed every 2-3 d, and were kept in vitro for up to 5 d, while islets were typically cultured for 1-2 d. Electrophysiology ␤ -cells or islets were superfused with a standard external solution containing (in mM) 115 NaCl, 3 CaCl 2 , 5 KCl, 2 MgCl 2 , 10 HEPES, 11.1 glucose (pH 7.2). The perforated patch-clamp technique was used to record islet or ␤ -cell membrane potentials or ion currents. Pipettes were pulled from borosilicate glass using a two-stage horizontal puller (P-97, Sutter Instruments). Pipette tips were filled with an internal solution containing (in mM) 28.4 K 2 SO 4 , 63.7 KCl, 11.8 NaCl, 1 MgCl 2 , 20.8 HEPES, 0.5 EGTA (pH 7.2) and then backfilled with internal solution plus 0.1 mg/ ml amphotericin B. An Axopatch-200B patch-clamp amplifier (Axon Instruments) was used in the standard tight-seal perforated patch-clamp mode to record membrane potentials or ion currents in current or voltage clamp mode, respectively (Hamill et al., 1981) . Pipette resistances ranged from 5 to 8 M ⍀ using our internal solutions, while seal resistances ranged from 2 to 10 G ⍀ .
Solutions were applied to ␤ -cells or islets using a gravity-driven perfusion system, which allowed switching between multiple reservoirs and flow rates in excess of 1 ml/min. All experiments were performed at 32 Њ C-35 Њ C using a feedback-controlled temperature regulation system (CellMicro Controls). All drugs were made up fresh daily from frozen stock solutions. Drugs and chemicals were obtained from Sigma-Aldrich with the exception of AZ and HMR1556, which were a gift from G.N. Tseng (VCU, Richmond, VA).
[Ca 2 ϩ ] i Measurements Cultured mouse islets were loaded with the Ca 2 ϩ -sensitive dye, fura-2/AM (Invitrogen). 2 mol/l fura-2-AM and 1 l of 2.5% pluronic acid were added to cells in 35-mm culture dishes containing 1 ml of medium, and islets were incubated for 30 min at 37 Њ C to load with dye. After loading, islets were washed once and then incubated in standard external solution for 20 min. [Ca 2 ϩ ] i was measured by placing islets in a small recording chamber mounted on the stage of an Olympus IX-50 inverted epifluorescence microscope (Olympus). Fura-2 was excited at 340/380 nm using a galvanometer-driven mirror that alternated a light beam from a xenon source ("HyperSwitch," IonOptix Corporation). A photomultiplier and photon counting were used to quantify fura-2 emission at 510 nm (IonOptix Inc.) . Fluorescence data were acquired and analyzed using IonWizard software (IonOptix).
[Ca 2 ϩ ] i values were determined from the fluorescence ratio (R) of Ca 2ϩ -bound fura-2 (excited at 340 nm) to unbound fura-2 (excited at 380 nM). Absolute [Ca 2ϩ ] i was determined using a standard equation (Grynkiewicz et al., 1985) . To convert R to [Ca 2ϩ ] i using this equation, R max and R min were obtained by exposing islets to 10 M ionomycin plus 3 mM Ca 2ϩ or 10 mM EGTA, respectively, at the end of each experiment. The equilibrium constant for Ca 2ϩ binding to fura-2 (K d ) was assumed to be 224 nM (Grynkiewicz et al., 1985) .
Measurement of Insulin Secretion
Islets were cultured overnight and then washed twice with our standard external saline containing 11.1 mM glucose. Following this, each dish containing 10 islets was incubated for 60 min in 1 ml of standard external solution containing various concentrations of glucose, UCL 1684, or AZ. A portion of the reaction solution was withdrawn at the end of the incubation period and diluted appropriately for insulin assay. Insulin was measured using an ELISA kit for detecting mouse insulin (Mercodia Ultrasensitive Mouse Insulin ELISA Kit; Mercodia), according to the instructions of the manufacturer. Sample absorbance at 450 nm was read using a microplate reader (model 2550, Bio-Rad Laboratories). Data were collected from four mice for UCL 1684 and four mice for AZ, and the experiment was repeated three times. The content of insulin in samples was calculated according to a standard curve.
Functional Expression of the hSK3 Gene in HEK 293
HEK 293 cells were cultured in minimal essential medium containing glutamine and 10% FBS. 1 or 2 d before transfection, cells were transferred to 35-mm Petri dishes and were grown to ‫%07ف‬ confluence. A mixture containing 0.1 g of the plasmid DNA encoding EGFP-N1 (BD Biosciences, CLONTECH Laboratories Inc.) and 1 g of plasmid DNA encoding human SK3 (Kohler et al., 1996; Chandy et al., 1998) was transfected into HEK 293 cells using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Cells were studied 24-48 h after transfection. SK3 currents were recorded using whole-cell patch clamp as described in general above. The electrodes used contained 28.4 mM K 2 SO 4 , 63.7 mM KCl, 10.7 mM NaCl, 20.8 mM HEPES, 1 mM MgCl 2 , 1 mM EGTA, 0.9 mM CaCl 2 , pH 7.2; the calculated [Ca 2ϩ ] i for this solution was ‫1ف‬ M, which is sufficient for nearly maximal activation of SK 3 channels (Kohler et al., 1996) . HEK 293 cells showing green fluorescence in the bath solution (115 mM NaCl, 3 mM CaCl 2 , 5 mM KCl, 2 mM MgCl 2 , 10 mM HEPES, 11.1 mM glucose, pH 7.35) were selected for voltage clamping. After the formation of a tight seal in cell-attached mode, the external solution was changed to an "SK blocking solution" (71 mM NaCl, 5 mM KCl, 2 mM MgCl 2 , 10 mM BaCl 2 , 30 mM TEA-Cl, 10 mM HEPES, 11.1 mM glucose, pH 7.35), which contained Ba 2ϩ and TEA to prevent SK current activation before establishing whole cell mode to help preserve cell viability. Once whole cell mode was established, SK3 currents were then initiated by using a high K ϩ external solution (90 mM NaCl, 30 mM KCl, 3 mM CaCl 2 , 2 mM MgCl 2 , 10 mM HEPES, 11.1 mM glucose, pH 7.35) and were recorded at Ϫ80 mV and ϩ10 mV. The effects of UCL 1684 and AZ on SK3 currents were observed by adding these drugs to the bathing solution.
Data analysis, curve fitting, and graphics were performed using IgorPro Software (Wavemetrics) and statistical analysis and curve fitting of dose-response data was done using GraphPad Prism Pro. Data shown are means Ϯ SEM. Where relevant, paired or unpaired Student's t tests were used to test for significance. P values Ͻ0.05 were considered significant and denoted by * or # in figures; P Ͻ 0.01 are denoted by ** or ## in figures; and P Ͻ 0.001 are denoted by *** or ### in figures.
R E S U L T S K slow Current Is Inhibited by the SK Blocker UCL 1684 in Mouse Single ␤-Cells
Mouse islet cells and insulin-secreting cell lines express SK channel isoforms, and SK channel modulators alter glucose-dependent [Ca 2ϩ ] i oscillations in mouse islets (Tamarina et al., 2003) . Paradoxically, however, the prototypical SK inhibitor apamin, which modulates [Ca 2ϩ ] i oscillations in rodent islets (Tamarina et al., 2003) , does not block K slow current in mouse ␤-cells (Göpel et al., 1999; Goforth et al., 2002) , and is without effect on islet electrical bursting (Lebrun et al., 1983) . The reasons for these discrepancies are not clear. To determine whether K slow is indeed mediated by SK channels, and to determine the role of K slow in islet stimulus-secretion coupling, we more fully characterized the pharmacological properties of K slow current.
To elicit K slow current, we used a standard protocol consisting of a physiological waveform command that resembled an islet burst to isolate a deactivation "tail" of K slow current. This protocol stepped membrane potential from Ϫ65 to Ϫ40 mV for 5 s, followed by a 5-s train of spike-like pulse depolarizations from Ϫ40 to 0 mV, and then a 10-s sojourn back to Ϫ40 mV (for more details of the protocol used, see Göpel et al., 1999) .
As shown in Fig. 1 A, upon application of the pulse train, an envelope of slow outward current progressively activated, with faster outward currents superposed, and then slowly deactivated once the pulse train was terminated. The peak amplitudes of the deactivating tail currents mediated by K slow are denoted by arrows in the figure, and were used to quantify the degree of K slow activation (Göpel et al., 1999; Goforth et al., 2002) .
As the bath application of up to 1 M apamin did not block K slow current (n ϭ 10, unpublished data), we tested the potent nonpeptide SK blocker UCL 1684, which is known to selectively target SK 1-3 type K Ca channels (Rosa et al., 1998) . As shown in Fig. 1 B, 10 nM UCL 1684 inhibited K slow current. In 17 isolated ␤-cells, the mean current density was reduced from 1.34 Ϯ 0.14 to 0.83 Ϯ 0.15 pA/pF (P Ͻ 0.001). K slow block by UCL 1684 was dose responsive, as shown in Fig. 1 C. The data were fit by a single binding site model to yield an IC 50 of 6.2 nM and a B max of 54.1%. This IC 50 is similar to the sensitivity of SK channels to UCL 1684 in other systems (Dunn, 1999; Malik-Hall et al., 2000; Hosseini et al., 2001) . The data are consistent with the hypothesis that SK channels are at least partly involved in the mediation of ␤-cell K slow current. In a previous study, Kanno et al. (2002) reported that K slow was a composite of K Ca and K ATP channels. In our hands, however, the K slow current of mouse ␤-cells was insensitive to 200 M tolbutamide (1.14 Ϯ 0.11 vs. 1.04 Ϯ 0.14 pA/pF, n ϭ 16, P Ͼ 0.05), as initially reported by Göpel et al. (1999) . This suggests that K slow current does not appear to be a mosaic of SK and K ATP currents using our standard conditions.
The Class III Antiarrythmic Drug AZ also Blocks K slow Current in Single Mouse ␤-Cells
In heart cells, the class III antiarrythmic agent AZ blocks both I Kr and I Ks delayed rectifying K ϩ currents, the former a fast, voltage-dependent K ϩ channel, and the latter a slowly activating K ϩ channel (Busch et al., 1994; Ohyama et al., 2001) . HMR 1556 is a selective blocker of I Ks in heart cells (Gögelein et al., 2000) . The antiarrythmic action of AZ is believed to occur due to prolongation of the cardiac action potential and increased relative refractoriness, both secondary to K ϩ current blockade (Busch et al., 1994; Fermini et al., 1995; Salata and Brooks, 1997; Karam et al., 1998) . As conventional K ϩ channel blockers like TEA did not show selectivity for K slow , and because I Ks in cardiac cells shows a similar slow deactivation characteristic, we decided to test whether two blockers of I Ks affect the ␤-cell K slow current. The bath application of AZ to ␤-cells resulted in the reversible and nearly complete suppression of K slow current (Fig. 2 A) . The addition of 3 M AZ reduced K slow current density from 1.68 Ϯ 0.31 to 0.77Ϯ 0.15 pA/pF (n ϭ 5, P Ͻ 0.05), and K slow blockade typically reached a steady-state level within 5 min. Fig. 2 B shows the doseresponse curve of AZ blockade of K slow , whose fit yielded an IC 50 of 3.2 M and a B max of 100% (n ϭ 5-8, P Ͻ 0.05), as shown in the figure. The IC 50 for K slow block by HMR 1556 was 127.3 nM (unpublished data). The sensitivity of K slow to AZ and HMR 1556 was generally similar to that reported for cardiac I Ks channels (Busch et al., 1994; Gögelein et al., 2000; Thomas et al., 2003) .
The blockade of K slow by AZ and HMR raised the possibility that I Ks rather than SK channels might mediate or at least contribute to mouse ␤-cell K slow current. To test this hypothesis, we isolated islets from mice lacking either KCNQ1 or KCNE1 genes due to a global deletion (Kupershmidt et al., 1999; Casimiro et al., 2001; Kondo et al., 2003) . It has been documented that I Ks current in heart cells is mediated by a heteromultimeric channel consisting of a KCNQ1 channel subunit and a KCNE1 ancillary subunit (Robbins, 2001) . The presence of KCNE1 significantly increases the amplitude and activation time constant of I Ks in heterologous expression systems (Seebohm et al., 2001; Melman et al., 2004) . As shown in Fig. 3 (A and B) , islet ␤-cells isolated from global KCNE1 or KCNQ1 knockout mice that lack cardiac I Ks (Kupershmidt et al., 1999) still exhibited slowly activating and deactivating, and AZ-sensitive K slow currents. The mean t 1/2 of K slow deactivation in wild-type ␤-cells was 1.9 Ϯ 0.2 s, n ϭ 16, and was not significantly different in ␤-cells from either KCNQ1 Ϫ/Ϫ or KCNE1 Ϫ/Ϫ islet ␤-cells (n ϭ 16 or n ϭ 24). The bar graphs shown in Fig. 3 (A and B) confirm that K slow current density was not significantly reduced in ␤-cells from either the KCNQ1 Ϫ/Ϫ or KCNE1 Ϫ/Ϫ mice. Furthermore, it is clearly apparent that 3 M AZ retained its ability to inhibit K slow current despite the lack of I Ks . This strongly suggests that AZ does not inhibit K slow by targeting channels composed of KCNQ1/KCNE1, and that, by extension, I Ks is unlikely to mediate K slow current in pancreatic ␤-cells.
To determine whether AZ also blocked K ATP , we test its effect on ␤-cell K ATP current recorded in whole cell patch clamp configuration. We found that whole cell K ATP conductance was unchanged by AZ. Thus, K ATP conductance varied from 3.35 Ϯ 0.36 to 3.30 Ϯ 0.39 nS measured from Ϫ80 to Ϫ20 mV in the absence or presence of AZ, respectively, n ϭ 6). Whole cell K ATP conductance was activated by dialyzing single mouse ␤-cells with a pipette solution lacking Mg-ATP. Taken together with data showing that K slow current was insensitive to tolbutamide, these findings show that K slow is not mediated by K ATP in our hands. Parenthetically, AZ also had no effect on the amplitude of voltage-dependent Ca 2ϩ current in ␤-cells (unpublished data).
AZ and UCL 1684 Block SK Channels Expressed in HEK Cells
Although AZ is known to interact with a variety of channels and receptors in other systems (for review see Green fluorescent cells were selected and the SK3 currents were recorded using the whole cell patch clamp configuration. As shown in figure, bath application of an SK blocking solution containing 10 mM BaCl 2 and 30 mM TEA-Cl, resulted in small basal currents. After replacing the external solution with 30 mM KCl, robust SK3 currents are observed (*, P Ͻ 0.05; **, P Ͻ 0.01, compared with the basal level). 10 nM UCL 1684 significantly inhibited this current at Ϫ80 mV (ii) or ϩ10 mV (iiii) (#, P Ͻ 0.05; ##, P Ͻ 0.01, n ϭ 6, bottom bar graph). (C) SK3-mediated currents in HEK 293 cells are also significantly blocked by AZ (##, P Ͻ 0.01, n ϭ 7). Brooks et al., 2001 ), a direct interaction with SK channels has not been previously reported. We thus tested the possibility that AZ inhibits K slow by directly inhibiting SK type channels. Cloned SK3 and eGFP genes were cotransfected into HEK 293 cells using standard techniques (see MATERIALS AND METHODS), and cells exhibiting green fluorescence were selected for patching (Fig. 4 A, left) . A bright field image of these cells is shown in Fig. 4 (right) .
As shown in Fig. 4 B, control recordings made using solutions containing 30 mM external KCl exhibited large inward currents at Ϫ80 mV (Fig. 4 B, i and ii, mean value of Ϫ46.1 Ϯ 6.9 pA/pF) and outward currents at ϩ10 mV (Fig. 4 B, iii and iiii, mean value of 36.2 Ϯ 11.1 pA/pF). Current increased following establishment of the whole cell mode when pipettes contained 1 M free calcium. To preserve cell viability while recording large SK currents, ␤-cells were initially bathed in a solution containing the reversible SK blockers Ba 2ϩ and TEA to inhibit osmotic stress due to SK activation and resulting large K ϩ fluxes. Following break in, Ba 2ϩ and TEA were then washed off the cells and 30 mM KCl added to the bath solution to measure SK current, and to test the sensitivity of the current to UCL 1684 or AZ (Wittekindt et al., 2004) . The current measured in HEK 293 cells dialyzed with 1 M [Ca 2ϩ ] i reversed at Ϫ70 mV, near the calculated potassium equilibrium potential (Ϫ80 mV, Shah and Haylett, 2000) , and showed a near-Nernstian shift when [K] o was increased from 5 to 30 mM (38 mV shift vs. 45 mV predicted).
As shown in Fig. 4 B (ii and iiii), SK3-mediated current was reduced ‫%06ف‬ by the addition of 10 nM UCL 1684 (from Ϫ46.1 Ϯ 6.9 to Ϫ18.0 Ϯ 2.0 pA/pF at Ϫ80 mV, or from 36.2 Ϯ 11.1 to 12.6 Ϯ 3.2 pA/pF at ϩ10 mV, P Ͻ 0.05, n ϭ 6). As shown in Fig. 4 C, the application of 10 M AZ also significantly inhibited SK3 current ‫%64ف‬ (from Ϫ55.5 Ϯ 12.2 to Ϫ29.0 Ϯ 6.9 pA/pF at Ϫ80 mV or from 68.5 Ϯ 14.0 to 36.9 Ϯ 7.9 pA/pF at ϩ10 mV, P Ͻ 0.01, n ϭ 7). The direct blockade of cloned SK3 current by either AZ or UCL 1684 supports the hypothesis that both UCL1684 and AZ block K slow in single ␤-cells by inhibiting an SK type K Ca current, although one that is insensitive to apamin (see DISCUS-SION). We believe this is the first report that AZ blocks SK-type K ϩ channels.
Functional Role of K slow in Mouse ␤-Cells and Islets
To elucidate the role of K slow current in mouse islets, we used UCL and AZ as probes for K slow participation in the physiological regulation of glucose-induced islet electrical activity, [Ca 2ϩ ] i , and insulin secretion from ␤-cells or islets.
As shown in Fig. 5 , the application of 10 nM UCL 1684 or 3 M AZ to single mouse ␤-cells that were firing rapid action potentials in 11.1 mM glucose resulted in a reversible membrane depolarization and significantly increased action potential firing. In the ␤-cells, sporadic action potentials or fast bursting were observed under control conditions (for detail of single ␤-cells firing properties, see Kinard et al., 1999; Zhang et al., 2003) . The addition of UCL 1684 depolarized the cells and increased the frequency of the spikes (Fig.  5, top) . In 13 ␤-cells, 10 nM UCL 1684 depolarized ␤-cell silent potential from Ϫ50.2 Ϯ 2.5 mV to Ϫ44.4 Ϯ 2.4 mV (P Ͻ 0.01), and increased the spike frequency from 58.8 Ϯ 18.9 min Ϫ1 to 133.7 Ϯ 31.4 min Ϫ1 (P Ͻ 0.01). Similar results were obtained using micromolar concentrations of AZ, as shown in the bottom trace of Fig.  5 . In eight cells, the addition of 3 M AZ depolarized ␤-cell potential from Ϫ48.3 Ϯ 3.7 mV to Ϫ41.3 Ϯ 2.5 mV (P Ͻ 0.01) and increased spike frequency from 76.4 Ϯ 25.0 min Ϫ1 to 146.6 Ϯ 44.5 min Ϫ1 (P Ͻ 0.05). These data suggest that K slow helps maintain the resting membrane potential of single ␤-cells, and acts as a brake to limit cell firing, as in other systems (Wolfart et al., 2001) . Decreased repolarization would also be expected if UCL 1684 inhibited rapid delayed recitifer outward K ϩ current (K V ) in ␤-cells, but the application of 10 nM UCL 1684 had no effect on whole cell K V current in parallel studies (unpublished data). The data are also in accord with our previous observation that ␤-cells exhibiting larger K slow currents tended to be more hyperpolarized (Goforth et al., 2002) . This would be expected if K slow contributed to the maintenance of the hyperpolarized silent phase potential of ␤-cells, along with K ATP .
In mouse islets, the addition of 11.1 mM glucose results in the appearance of electrical bursting (Ashcroft and Rorsman, 1989; Zhang et al., 2003) . As shown in Figure 5 . Bath application of K slow blockers in 11.1 mM glucose depolarize mouse isolated ␤-cells and increase the frequency of action potential firing. The perforated patch clamp technique was used to record the membrane potential of single mouse ␤-cells. Cell 1 (top trace) shows a representative sample from 13 recordings before and after bath addition of 10 nM UCL 1684. Cell 2 (bottom trace) shows a representative sample from eight recordings before and after bath application of 3 M AZ. Fig. 6 A, medium (top) as well as slow bursting islets (bottom) were similarly affected by K slow blockade. Thus, the application of 6 M AZ to islets bathed in 11.1 mM glucose reversibly depolarized islets and increased action potential frequency. While some fast membrane repolarization could still be observed in the presence of AZ (arrow; Fig. 6 A, bottom), these repolarizing events appeared to be much shorter than in the absence of drug, and the mean silent phase potential was significantly depolarized by AZ (from Ϫ54.4 Ϯ 2.3 mV vs. Ϫ43.9 Ϯ 2.7 mV, n ϭ 13, P Ͻ 0.001).
UCL 1684 or AZ addition also reproducibly modulated the [Ca 2ϩ ] i responses of islets exposed to 11.1 mM glucose. Thus, UCL 1648 increased the [Ca 2ϩ ] i level corresponding to the membrane silent phase (solid line), and increased the frequency of islet [Ca 2ϩ ] i oscillations (Fig. 6 B, representative of 10 islets). Mean [Ca 2ϩ ] i increased from 269.4 Ϯ 18.8 nM to 328.6 Ϯ 16.2 nM after treatment with 100 nM UCL (P Ͻ 0.05). The application of 6 M AZ to islets increased the frequency of islet [Ca 2ϩ ] i oscillations and the mean [Ca 2ϩ ] i level from 288.4 Ϯ 18.3 to 322.6 Ϯ 23.1 nM (n ϭ 7, P Ͻ 0.05).
Blocking K slow Potentiates Mouse Islet Insulin Secretion in a Glucose-dependent Manner
The increase in [Ca 2ϩ ] i we observed following K slow blockade suggested that glucose-dependent insulin secretion might also be increased by UCL 1684 or AZ. While 10 and 100 nM UCL 1684 had no effect on basal insulin secretion (measured in 2.8 mM glucose (P Ͼ 0.05), these concentrations increased glucose-stimulated insulin secretion from 722.3 Ϯ 42.7 to 919.4 Ϯ 54.2 or 1096.0 Ϯ 54.2 pg · l Ϫ1 · islet Ϫ1 · h Ϫ1 , respectively (Fig. 7 A, P Ͻ 0.01, n ϭ 8).
AZ also potentiated glucose-dependent insulin secretion as shown in Fig. 7 B. Thus, basal insulin release in 2.8 mM glucose was 264.7 Ϯ 19.7 pg · l Ϫ1 · islet Ϫ1 · h Ϫ1 . When glucose concentration was increased to 11.1 mM, insulin release increased to 722.3 Ϯ 42.7 pg · l Ϫ1 · islet Ϫ1 · h Ϫ1 . The addition of 3.0 or 10.0 M AZ significantly enhanced islet insulin release by 34.8% and 68.4%, respectively (Fig. 7 B , PϽ 0.01, n ϭ 8).
The similar potentiating effects of these two structurally unrelated K slow blockers suggest that targeting this channel may represent a new pharmacological approach for increasing insulin release from the pancreas without also producing hypoglycemia (MacLeod, 2004) . Thus, blockers of K slow such as AZ and UCL 1684 could work in a similar manner to the K ATP channelblocking sulfonylureas, as both drug types block a resting K ϩ conductance, resulting in cell membrane depolarization, increased Ca 2ϩ uptake, and increased insulin exocytosis (Ferner and Neil, 1988; Aguilar-Bryan et al., 1995; Philipson and Steiner, 1995) . However, in the case of K slow blockers, insulin secretion would only be amplified when glucose was already elevated, reducing the possibility of hypoglycemia, a drawback of the sulfonylureas (Ferner and Neil, 1988) . K slow blockade is expected to require elevated glucose for it to be effective, since ␤-cell depolarization due to K ATP closure by glucose must first occur for [Ca 2ϩ ] i to rise sufficiently to activate K slow (Göpel et al., 1999; Goforth et al., 2002) . Under basal condition, [Ca 2ϩ ] i would be too low to sufficiently activate K slow .
D I S C U S S I O N

SK Channels Mediate K slow Current in Mouse ␤-Cells
While there is agreement in the field that K slow is mediated at least in part by a Ca 2ϩ -activated K ϩ channel in pancreatic ␤-cells, the specific channel involved has been controversial. Thus, while the insensitivity of K slow to charybdotoxin, which blocks the large conductance BK type K Ca channels of ␤-cells (Kukuljan et al., 1991; Li et al., 1999) , specifically rules out mediation by BK channels, SK mediation has been unclear because apamin, a bee venom peptide that selectively blocks SK but not BK channels, has yielded disparate results, with one group reporting effects of the toxin on islet Ca 2ϩ oscillations (Tamarina et al., 2003) , while two other groups reporting that K slow current was insensitive to apamin (Göpel et al., 1999; Goforth et al., 2002) .
We thus considered other pharmacological agents in an attempt to further clarify matters. The sensitivity of K slow current to the nonpeptide SK inhibitor UCL 1684, and its insensitivity to the IK (Ca) (or SK4) inhibitor chlortrimazole (0.94 Ϯ 0.07 vs. 0.94 Ϯ 0.08 pA/pF, n ϭ 10, P Ͼ 0.05) suggests that K slow current is mediated at least in part by SK channels similar to SK1, 2, or 3, although the ␤-cell isoform involved must be apamin insensitive.
Further evidence in favor of K slow mediation by SK channels was obtained with AZ, which readily blocked K slow current and which up to now has been discussed as a selective inhibitor of the slow delayed rectifier current in heart, I Ks (Busch et al., 1994) . We ruled out that islet K slow current included a contribution from a cardiac-like I Ks , as AZ-blockable K slow current persisted in islets obtained from KCNQ1 or KCNE1 null mice lacking I Ks , which in cardiac cells is formed by the coexpression of KCNQ1 and KCNE1 subunits (Barhanin et al., 1996) . Moreover, showing that AZ can directly block heterologously expressed hSK3 channels in HEK cells suggests SK mediation of K slow current. However, the apamin sensitivity of hSK3 suggests it is unlikely that SK3 is the isoform that mediates K slow in ␤-cells (Tamarina et al., 2003) . The fact that the extended currentvoltage curves we observed in some native ␤-cells had the pronounced inward rectification expected of SK currents (unpublished data; Soh and Park, 2001 ) further supports the hypothesis that SK channels mediate K slow in ␤-cells.
We also briefly considered the possibility that apamin-insensitive K Ca channels such as those that mediate the slow afterhyperpolarization of CNS neurons (sAHP; Vogalis et al., 2003; Stocker et al., 2004 ) might be involved in mediating ␤-cell K slow current. However, this seems to be unlikely given that the neuronal sAHP, which is believed to be mediated by a non-SK type isoform is insensitive to the UCL compounds (Shah et al., 2001; Bond et al., 2004) . Furthermore, the kinetic properties of sAHP would appear to be slower than for ␤-cell K slow current (Vogalis et al., 2003) .
While it might appear paradoxical that K slow could be mediated by an apamin-insensitive SK isoform, recent studies have revealed that alternative splicing of the SK Figure 7 . (A) UCL 1684 enhanced glucose-dependent insulin secretion from mouse islets. Islets were treated with different concentrations of UCL 1684 for 1 h using either basal (2.8 mM) or high (11.1 mM) glucose. Data shown were collected from four mice. ***, P Ͻ 0.001 vs. 2.8 mM glucose group. ##, P Ͻ 0.01; ###, P Ͻ 0.001 vs. untreated 11.1 mM glucose group. (B) AZ also increased insulin release from islets in 11.1 mM glucose. Data shown were obtained using islets isolated from four different mice. ***, P Ͻ 0.001 vs. 2.8 mM glucose group. ##, P Ͻ 0.01; ###, P Ͻ 0.001 vs. untreated 11.1 mM glucose group. gene can yield splice variants that are relatively insensitive to apamin, as we found for K slow (e.g., SK3_ex4; Wittekindt et al., 2004) , and that combining different SK subunits in a heteromultimeric assembly can modify SK channel pharmacology (Benton et al., 2003; Monaghan et al., 2004; D'hoedt et al., 2004 ). While we cannot at present select among these possibilities, further work is required to clone and sequence the ␤-cell-specific SK isoforms. A recent paper reported that SK1-4 are all expressed in islet tissue and ␤-cell lines, although whether these isoforms are ␤-cell specific was not determined (Tamarina et al., 2003) . We found that either UCL 1684 or AZ inhibited K slow current in a dose-dependent manner in mouse ␤-cells, leading to increased membrane depolarization, action potential firing, and, concomitantly, elevated [Ca 2ϩ ] i and insulin secretion. These findings broadly support the hypothesis that K slow plays an important role in the genesis of islet electrical activity, as has been proposed (Göpel et al., 1999; Goforth et al., 2002) but not previously demonstrated experimentally. We found that K slow activation contributes to ␤-cell membrane potential during the silent phase of bursting, and may play a role in terminating the cyclic bursts of Ca 2ϩ -dependent action potentials that drive Ca 2ϩ influx and insulin secretion in mouse islets. Similar findings were observed in neurons following inhibition of slow Ca 2ϩ -activated currents like sAHP (El Manira et al., 1994; Ghamari-Langroudi and Bourque, 2004) . While the activation and deactivation kinetics of K slow are relatively brief given the more prolonged nature of electrical bursting observed in islets, modeling studies have previously shown that fast K slow may interact with slower process in the ␤-cells (e.g., K ATP via ATP/ADP changes; ER Ca 2ϩ ) to mediate slower modes of electrical activity (Bertram et al., 2000; Bertram and Sherman, 2004a,b) . K slow may also display slower deactivation kinetics during more prolonged phases of Ca 2ϩ influx than provided experimentally here. Alternatively, we cannot rule out that in situ the kinetics of K slow current are slower than we observed in the isolated ␤-cells. There is currently much interest in the islet field in investigating novel targets for drugs that might increase insulin secretion in a glucose-dependent manner (MacLeod, 2004) . Our work suggests that inhibition of K slow could be useful clinically, as K slow appears to help control Ca 2ϩ influx into the ␤-cell when glucose is elevated and that its inhibitors significantly enhance insulin secretion. Targeting K slow pharmacologically may thus provide a novel, glucose-sensitive target for a new generation of antidiabetic agents. 
